“Tirzepatide: Dual GIP GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”. 2024. InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes 1 (2): 96-110. https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12.